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Abstract
Background: Obesity has become a leading global health problem owing to its strong association with a high
incidence of diseases.
Aim: To induce rat obesity using high fat diet (HFD) and to estimate oxidative stress markers in their liver, heart
and kidney tissues in order to shed the light on the effect of obesity on these organs.
Materials and methods: Sixty white albino rats weighing 150-200 g were randomly divided into two equal
groups; group I: received high fat diet for 16 weeks, and group II (control group): received only normal diet (rat
chow) for 16 weeks. Blood samples were taken for measurement of lipid profile, tissue samples from liver, heart
and kidney were taken for determination of malondialdehyde (MDA), protein carbonyl (PCO), reduced glutathione
(GSH) levels, and the activities of glutathione S- transferase (GST) glutathione peroxidase (GPx), catalase (CAT) and
paraoxonase1 (PON1) enzymes.
Results: Data showed that feeding HFD diet significantly increased final body weight and induced a state of
dyslipideamia. Also our results showed a significant increase MDA and PCO levels in the hepatic, heart and renal
tissues of obese rats, as well as a significant decrease in the activity of GST, GPx and PON 1 enzymes. On the other
hand CAT enzyme activity showed significant decrease only in renal tissues of obese rats with non significant
difference in hepatic and heart tissues. GSH levels showed significant decrease in both renal and hepatic tissues of
obese animals and significant increase in their heart tissues. Correlation studies in obese animals showed a
negative correlation between MDA and PCO tissue levels and the activities of GPx, GST and PON1 in all tissues and
also with CAT enzyme activity in renal tissues. Also a negative correlation was detected between MDA & PCO
tissues levels and GSH levels in both hepatic and renal tissues. While positive correlation was found between them
and GSH levels in heart tissues.
Conclusion: High fat diet-induced obesity is accompanied by increased hepatic, heart, and renal tissues oxidative
stress, which is characterized by reduction in the antioxidant enzymes activities and glutathione levels, that
correlate with the increase in MDA and PCO levels in most tissues. This may probably contribute to the additional
progression of obesity related problems.
Introduction
Obesity is a pathological condition in which excess body
fat has accumulated to the extent that it may have an
adverse effect on health, leading to reduced life expec-
tancy and/or increased health problems [1]. The induc-
tion of obesity may be performed in animals by
neuroendocrine, dietary or genetic changes [2]. The
great similarity and homology between the genomes of
rodents and humans make these animal models a major
tool to study obesity [2].
Oxidative stress is highly correlated with a wide vari-
ety of inflammatory and metabolic disease states, includ-
ing obesity [3, 4, and 5]. It is highly correlated with
c u m u l a t i v ed a m a g ei nt h eb o d yd o n eb yf r e er a d i c a l s
inadequately neutralized by antioxidants [6]. It has been
* Correspondence: nooman1234@hotmail.com
Medical Biochemistry Department, Faculty of Medicine, Tanta University,
Egypt
Noeman et al. Diabetology & Metabolic Syndrome 2011, 3:17
http://www.dmsjournal.com/content/3/1/17
METABOLIC SYNDROME
DIABETOLOGY & 
© 2011 Noeman et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.shown that free radicals may adversely affect cell survi-
val because of membrane damage through the oxidative
damage of lipid, protein and irreversible DNA modifica-
tion [7]. Lipid peroxidation such as thiobarbituric acid
reactive substances and hydroperoxides levels as well as
markers of protein oxidation such as carbonyl proteins
are markers of oxidative damage of ROS [8,9].
Furthermore oxidative damage is aggravated by the
decrease in antioxidant enzymes activities such as super-
oxide dismutase, catalase (CAT), glutathione S-transfer-
ase (GST), and glutathione peroxidase (GPx) which acts
as a free radical scavengers in conditions associated with
oxidative stress [10].
Paraoxonase (PON1) is another antioxidant enzyme
closely associated with high-density lipoproteins. It is a
calcium-dependent esterase, which detoxifies lipid per-
oxides, and is widely distributed in many tissues, includ-
ing the liver, brain, lung, heart, kidneys, small intestine
and aorta [11].
Evidence suggests that a clustering of sources of oxi-
dative stress exists in obesity; hyperglycemia, increased
tissue lipid levels, inadequate antioxidant defenses,
increased rates of free radical formation, and chronic
inflammation [12]. Obesity affected many organs in the
body such as liver, heart and kidney. Fatty liver and
nephropathy are commons complication of obesity [13].
Arthrosclerosis and cardiac complications are more
common among obese individuals [14,15].
Therefore the present study was designed to investi-
gate the development of obesity in response to a high
fat diet (HFD) and to estimate oxidative stress markers
in the liver, heart and kidney in obese rats to shed the
light on the effect of obesity on these organs.
Materials and methods
This study was carried out on 60 white males and
females’ albino rats, their weight ranged between 150-
200 g. During the study the animals were kept in wire
mesh cages with ad libitum access to water. The room
temperature was about 22-24°C and the animals were
exposed to 12:12 hours light dark cycles. The animals
were randomly divided into two equal groups:
Group I: received the high fat diet for 16 weeks.
Group II (control group): received only normal diet ad
l i b i t u m( r a tc h o w )f o r1 6w e e k s .C o m p o s i t i o no ft h e
experimental diet (g/kg diet) was according to the for-
mula of Kim et al. [16] with some modefications. It
included the normal diet for control rats (Fat 5% [corn
oil 5%], carbohydrates 65% [corn starch 15% and sucrose
50%], proteins 20.3% [casein 20% and DL-Methionine
3%], fiber 5%, salt mixture 3.7%, and vitamin mixture
1%). The high fat diet contained (fat 46% [corn oil
25.5%, and beef tallow 20.5%], carbohydrates 24% [corn
starch 6% and sucrose 18%], proteins 20.3% [casein 20%
and DL-Methionine 3%], fiber 5%, salt mixture 3.7%,
and vitamin mixture 1%).
Normal and HFD constituents were purchased from
E l - G o m h o r i aC o m p a n y ,C a i r o ,E g y p t .H F Dw a sp r e -
served at 4°C until used. Obesity was induced in 16
weeks.
Our work was carried out in accordance with the
guidelines of the Ethical Committee of Medical Research
of Faculty of Medicine Tanta University.
Sample collection
By the end of the experimental period, all rats were
sacrificed and blood samples were collected. Sera were
separated and stored in aliquots at -70°C till used for
estimation of lipid profile including; total cholesterol
[17], triglycerides [18], LDL-cholesterol, VLDL [19], and
HDL-cholesterol [20], by enzymatic colorimetric meth-
ods using commercial kits.
Then the abdomen and the thorax were opened and
both liver, kidneys and heart were removed, washed
three times in ice cold saline and blotted individually on
ash-free filter paper, used for preparation of tissue
homogenates for estimation of tissue MDA, PCO, GSH
levels and the activity of GST, GPx, CAT and PON1
enzymes.
Preparation of tissue homogenates
Specimens from each organ were separated into three
parts. Each piece was weighted and homogenized sepa-
rately with a potter- Elvenhjem tissue homogenizer One
part was homogenized in phosphate buffer saline (PBS)
50 mM pH (7.4) for estimation of protein content, GST,
CAT enzymes activities and GSH level, the second was
homogenized in potassium phosphate buffer 10 mM pH
(7.4) for estimation of MDA, PCO levels and GPx activ-
ity, and the third in Tris- HCl 100 mM, pH (8) for esti-
mation of PON1 activity. The crude tissue homogenate
was centrifuged at 10,000 rpm, for 15 minutes in cold
centrifuge, and the resultant supernatant was used for
the different estimations. Protein content in tissue
homogenate was measured according to the method of
Lowry et al. [21].
Chemicals
Cummene hydroperoxide, 1-chloro-2, 4-dinitrobenzene
(CDNB), 5-5-dithiobis-2-nitrobenzoic acid (DTNB) para-
oxon and Dinitrophenylhydrazine (DNPH) were
obtained from (Sigma chemical Co. St., Louis, MO,
USA). Thiobarbituric acid (TBA) and reduced glu-
tathione (GSH) were obtained from Fluka Chemical Co.
Trichloroacetic acid (TCA) were obtained from Merk
Chemical Co USA. Acetic acid, potassium dichromate,
hydrogen peroxide, hydrochloric acid and ethanol were
obtained from El-Nasr chemical Co.
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and GSH levels
MDA
This method depends on the formation of MDA as an
end product of lipid peroxidation which reacts with
thiobarbituric acid producing thiobarbituric acid reactive
substance (TBARS), a pink chromogen, which can be
measured spectrophotometrically at 532 nm, an MDA
standard was used to construct a standard curve against
which readings of the samples were plotted [22].
PCO
This method depends on the formation of a Schiff base
from the reaction of dinitrophenylhydrazine with protein
carbonyls to form protein hydrazones which was mea-
sured spectrophotometrically. Briefly, after precipitation
of protein with an equal volume of 1% trichloroacetic
acid, the pellet was resuspended in 10 mmol/L DNPH
p l u s2 NH C l ,o ri n2 NH C la sac o n t r o lb l a n k .N e x t ,
after the washing procedure with 1:1 ethanol-ethylace-
tate, the final palette was dissolved in 6 mol/L guani-
dine. The carbonyl group was determined from the
absorbance at 370 nm. The carbonyl content was calcu-
lated in terms of nmol/mg protein [23,24].
GSH
The method is based on the reduction of 5,5 dithiobis
(2-nitrobenzoic acid) (DTNB) with reduced glutathione
(GSH) to produce a yellow compound. The reduced
chromogen is directly proportional to GSH concentra-
tion and its absorbance can be measured at 405 nm by
using a commercial kit was used (Biodiagnostic, Egypt)
[25].
Enzymatic Assays
Tissues GST enzyme activity: it measures the conjuga-
tion of 1-chloro-2,4-dinitro benzene (CDNB) with
reduced glutathione that produces a dinitrophenyl
thioether which can be detected by spectrophotometer
at 340 nm. One unit of GST activity is defined as the
amount of enzyme producing 1 mmol of CDNB-GSH
conjugate/min under the conditions of the assay accord-
ing to the method described by Habig et al. [26].
Tissues GPx enzyme activity: it was measured as IU/
gm wet tissue by the reaction between glutathione
remaining after the action of GPx and 5, 5-dithiobis-(2-
nitrobenzoic acid) to form a complex that absorbs maxi-
mally at 412 nm. Glutathione peroxidase activity of 1 U/
mg protein was defined as 1 μg of GSH consumed/min/
mg protein [27].
Determination of tissues CAT enzyme activity: it
assayed by the method of Sinha which based on forma-
tion of chromic acetate from dichromate and glacial
acetic acid in presence hydrogen peroxide, chromic acet-
ate that produced was measures colorimetrically at 570
nm, one enzyme unit was defined as the amount of
enzyme which catalyzed the oxidation of 1 μmole H2O2
per minute under assay conditions [28].
Tissues PON1 enzyme activity: PON1 activity towards
paraoxon (O,O-diethyl-O-p-nitrophenyl phosphate) was
determined by measuring the initial rate of substrate
hydrolysis to p- nitrophenol, whose absorbance was
monitored at 405 nm in the assay mixture, A PON1
activity of 1 U/mg protein was defined as 1 μmol p-
nitrophenol formed per minute per mg protein [29].
Statistical analysis
All the statistical analyses were processed using Statisti-
cal Program of Social Sciences (SPSS) for windows, ver-
sion 10.0. Values of the measured parameters were
expressed as mean value ± SD and the difference
between the two groups was determined using unpaired
student’s t-test, and the significance was considered at p
values <0.05. Correlation between variables was evalu-
ated using Pearson’s correlation coefficient with level of
significance <0.05.
Results
By the end of the 16 weeks there was a significant
increase in the weight of high fat diet fed rats; (group I)
compared to the control (group II), (Figure 1). Also
there was significant increase in serum levels of total tri-
glycerides, total cholesterol, LDL-cholesterol and VLDL-
cholesterol with low level of HDL-cholesterol in obese
rats as compared with the control (Table 1).
Our results showed a statistically significant increase
in the hepatic tissues levels of MDA and PCO in obese
rats when compared to the control group, (p < 0.05).
Concerning the antioxidant enzymes activities in obese
animals, the present study showed a statistical signifi-
cant decrease in the activities of hepatic GST, GPx and
PON 1 enzymes, and also decrease in hepatic GSH level
in obese rats compared to control. Non significant
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Figure 1 Comparison between the two studied groups as
regards body weight.
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the two groups, (p >0.05) (Table 2).
The present study also showed significant increase
heart tissues level of MDA and PCO in obese animals
than the control. There was significant decrease in heart
GST, GPx, and PON 1 enzymes activities, with no sig-
nificant difference in CAT enzyme activity in obese rats,
(p >0.05). GSH heart tissues level showed a significant
increase in obese animals (Table 3).
Table 4 showed significant increase of renal tissue
levels of MDA and PCO in obese rats as compared to
the control group. Also there was a significant decrease
in the activities of renal GST, GPx, CAT and PON 1
enzymes in obese rats. GSH level showed a significant
decrease in obese rats than the control.
The correlation matrix in our study showed that in
obese animals there was a negative correlation between
MDA and PCO levels and the activities of GPx, GST
and PON1 in the hepatic, heart and renal tissues and
with CAT enzyme activity in renal tissues. No correla-
tion was detected between MDA or PCO tissue levels
and CAT enzyme activity in the hepatic and heart tis-
sues. A negative correlation was detected between
MDA, PCO levels and GSH levels in both hepatic and
renal tissues. Positive correlation was found between
heart MDA and PCO levels and the GSH level (Tables
5, 6, 7).
Discussion
Obesity is a strong risk factor for developing dyslipide-
mia [30,31], diabetes mellitus [32], fatty liver (which can
later progress to nonalcoholic fatty liver disease [33],
cardiovascular (CV) diseases such as heart failure (HF)
and coronary heart disease (CHD) [15].
Feeding of (HFD) to rats was proved to be a useful
model of putative effects of dietary fat in humans [34].
Rat models are therefore useful tools for inducing obe-
sity as they will readily gain weight when fed high-fat
diets [2].
In the present study, obesity was induced in white
albino rats by using a high fat diet formula. Obesity was
induced in 16 weeks. The weight gained by rats fed HFD
formula, was significantly more than that gained by those
fed the normal diet. Many workers were able to induce
obesity in rats using different formulas of high fat diets
[16,35-38]. The response of animals to the HFD is a
subtle but cumulative effect, because it took over a 10
weeks period. The difference in weight gain in all above
studies may be due to age, genetic makeup of the differ-
ent strains and composition of different formulas [35,36].
HDF resulted in dyslipidemic changes as illustrated by
increasing serum levels of triacylglyceral, total choles-
terol, LDL-cholesterol and VLDL-cholesterol and low
level of HDL cholesterol as compared with control; a
finding in accordance with that of Woo et al [39], and
Kamal and mohamed [40]. Dyslipidemic changes occurs
in obesity may be due to the increased triacylglycerol,
content of the liver due to increased influx of excess
NEFAs into the liver[41]. It has been revealed that
altered lipid concentrations and qualitative changes of
the lipoprotein fractions in obesity are associated with
an increased risk of various adverse effects of obesity
[42,43]. Additionally, lipid alterations have been consid-
ered as contributory factors to oxidative stress in obesity
[44]. Increased production of reactive oxygen species as
well as reduced antioxidant defense mechanisms have
been suggested to play a role in both humans and ani-
mal models of obesity [3,45].
Lipid peroxidation is thought to be a component of
obesity-induced pathology [46]. The data presented in
this study showed that obesity increased lipid peroxida-
tion in hepatic, cardiac and renal tissues as expressed by
increased tissue levels of MDA.
Table 1 Statistical comparison between all studied
groups as regards to lipid profile
Parameter Group I
(n = 30)
Group II
(n = 30)
P
Total triglycerdies (mmol/L) 0.92 ± 7.75 0.64 ± 9.19 P <0.05*
Total cholesterol (mmol/L) 3.27 ± 0.23 2.32 ± 0.05 P <0.05*
LDL-cholesterol (mmol/L) 1.74 ± 0.043 0.86 ± 0.05 P <0.001*
HDL-cholesterol (mmol/L) 1.02 ± 0.06 1.9 ± 0.05 P <0.001*
VLDL-cholesterol (mmol/L) 0.79 ± 0.01 0.36 ± 0.01 P <0.001*
Table 2 Statistical comparison between all studied parameters in liver tissues.
Parameter Group I
(n = 30)
Group II
(n = 30)
P
MDA (nmol/g wet tissue) 93.30 ± 9.63 21.7 ± 5.66 P <0.05*
Protein carbonyl (nmol/g wet tissue) 26.44 ± 2.32 20.16 ± 1.13 P <0.05*
GSH (mg/g/g wet tissue) 93.32 ± 9.62 124.2 4 ± 1.39 P <0.05*
GST (μmol/g wet tissue) 343.7 ± 21.36 470.9 ± 22.9 P <0.05*
GPx (IU/g wet tissue) 21.85 ± 2.68 29.14 ± 1.76 P <0.05*
CAT (μmol H2O2 consumed/mg protein/min) 664.26 ± 6.66 665.80 ± 6.77 P > 0.05
PON 1 (U/mg protein/min) 151.833 ± 61.55 284.31 ± 110.60 P <0.05*
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Vincent, et al., [47], Olusi et al., [8], and Amirkhizi et
al., [46] who showed that, obesity is an independent risk
factor for increasing lipid peroxidation and decreased
activity of cytoprotective enzymes. Obesity can cause
increased lipid peroxidation by progressive and cumula-
tive cell injury resulting from pressure of the large body
mass. Cell injury causes the release of cytokines, espe-
cially tumor necrosis factor alpha (TNF-a) which gener-
ates ROS from the tissues which in turn cause lipid
peroxidation [48]. The hypertriglyceridemia seen in
obese rats may contribute to the alteration in the oxi-
dant-antioxidant balance, suggesting that an increase in
the bioavailability of free fatty acids can increase lipid
peroxidation [46].
Cellular proteins are believed to be the target of free
radical-induced oxidative injury. Protein carbonyl (PCO)
content of liver, heart and kidney is increased signifi-
cantly in obese rats compared to normal rats. Increasing
PCO in obesity may be due to damage of cellular pro-
teins by ROS generated in obesity. The accumulation of
oxidized proteins might impair the cell function. The
use of PCO as a marker for measuring of damaged pro-
teins may have some advantages over other markers,
because of relatively early formation, greater stability
and reliability and also their longer life-span [49].
There are several potential mechanisms for of the
increasing lipid peroxidation and protein carbonyl in
hepatic, cardiac and renal tissues. Reactive oxygen spe-
cies (ROS) and lipid peroxidation products impaired the
respiratory chain in hepatocytes either directly or
indirectly through oxidative damage to the mitochon-
drial genome. These features, in turn, lead to the gen-
eration of more ROS, and a vicious cycle ensues.
Mitochondrial dysfunction can also lead to apoptosis or
necrosis depending on the energy status of the cell.
Finally, ROS and lipid peroxidation products also acti-
vate stellate cells, thus resulting in fibrosis [50,51].
Lipid peroxidation in the heart leads to loss of the cel-
lular membrane integrity due to oxidative modification
of lipids and proteins that can ultimately lead to cardiac
arrhythmias, poor contractility, infarction, cardiac failure
or sudden death [47]. The potential mechanism for
increased lipid peroxidation in cardiac tissue may be
due increased lipid substrate within the myocardium in
which can serve as a larger target for oxidation by free
radicals [47,52]. It is well established that elevated myo-
cardial work and mechanical overload is associated with
increased free radical production consequently lipid per-
oxidation [53]. Mechanical overload-induced increases
in muscle oxygen consumption accelerate electron flux
through the mitochondria in proportion to the need for
ATP. This results in increased electron leakage from the
electron transport chain and increased production of
superoxide anions [47].
Several mechanisms may contribute to the onset and/
or the progression of renal involvement in experimental
obesity among them; lipid peroxidation and oxidative
stress have been frequently proposed. HFD induces
alteration of renal lipid metabolism by an imbalance
between lipogenesis and lipolysis in the kidney, as well
as systemic metabolic abnormalities and subsequent
Table 3 Statistical comparison between all studied parameters in the heart tissues.
Parameter Group I
(n = 30)
Group II
(n = 30)
P
MDA (nmol/g wet tissue) 29.38 ± 4.75 48. 99 ± 4.40 P <0.05*
Protein carbonyl (nmol/g wet tissue) 18.4 ± 1.95 22.86 ± 2.95 P <0.05*
GSH (mg/g/g wet tissue) 90.54 ± 5.59 98.2 ± 3.67 P <0.05*
GST (μmol/g wet tissue) 289.6 ± 16.95 261.158 ± 62.09 P <0.05*
GPx (IU/g wet tissue) 26.1 ± 2.06 20.9 ± 2.06 P <0.05*
CAT (μmol H2O2 consumed/mg protein/min) 591.8 ± 4.75 586.5 ± 9.5 P >0.05
PON 1 (U/mg protein/min) 188.54 ± 58.62 115.74 ± 30.26 P <0.05*
Table 4 Statistical comparison between all studied parameters in the kidney tissues.
Parameter Group I
(n = 30)
Group II
(n = 30)
P
MDA (nmol/g wet tissue) 69.09 ± 6.43 41.32 ± 4.79 P < 0.001*
Protein carbonyl (nmol/g wet tissue) 26.54 ± 3.4 18.86 ± 1.69 P < 0.001*
GSH (mg/g wet tissue) 89.89 ± 1.9 101 ± 2.38 P < 0.001*
GST (μmol/g wet tissue) 223.97 ± 10.459 258.76 ± 16.6 P < 0.001*
GPx (IU/g wet tissue) 20.94 ± 2.85 28.55 ± 4.779 P < 0.001*
CAT (μmol H2O2 consumed/mg/protein/min) 577.37 ± 7.69 585.9 ± 3.7 P < 0.001*
PON 1 (U/mg protein/min) 93.23 ± 12.45 112.43 ± 15.32 P < 0.001*
Noeman et al. Diabetology & Metabolic Syndrome 2011, 3:17
http://www.dmsjournal.com/content/3/1/17
Page 5 of 8renal lipid accumulation and lipid peroxidation leading
to renal injury [54]. The accumulation of adipose tissue
around the kidneys of obese rats penetrates into the
medullary sinuses thus increased intrarenal pressures
which may cause damage the renal tissue. Damaged
renal tissue acts as sources of ROS and develops lipid
peroxidation. An increased lipid peroxidation in the kid-
ney tissue, as well as modification of the circulating
LDL/VLDL fraction, is probably involved in the onset of
kidney lesions in this normoglycaemic rodent model of
obesity [55].
It has been shown that animal body had an effective
mechanism to prevent the free radical induced tissue
cell damage, this accomplished by a set of endogenous
antioxidant enzymes and protein such as GST, SOD,
CAT, GPX, GRD and GSH. When the balance between
ROS production and antioxidant defense is lost oxida-
tive stress results; which through a serious of events
deregulates the cellular functions leading various patho-
logical conditions [10]. GST, CAT and GPX constituted
a mutually supportive team of defense against reactive
oxygen species. In the present study GST, CAT, GPX
and PON 1 enzymes activity and GSH protein were
measured in hepatic, cardiac and renal tissue and the
data showed clearly a significant decrease in the activ-
ities of GST, GPx and PON 1 enzymes in liver, heart
and renal tissues in obese rats as compared to the con-
trol group. Catalase (CAT) enzyme showed a non signif-
icant change in hepatic and heart tissues and decreased
in renal tissues of obese rats. GSH level showed signifi-
cant decrease in both liver and renal tissues in obese
rats. While its level in heart tissues showed significant
increase in obese rats. Our results were in agreement
with many authors [[8,47,50] and [55]]. There are sev-
eral mechanisms explaining the reduction of antioxidant
enzymes in obese rats;
The increased lipid peroxidation lead to inactivation of
the enzymes by crosses linking with MDA; this will
cause an increased accumulation of superoxide, H2O2
and hydroxyl radicals which could further stimulate
lipid peroxidation. This mechanism has a clue from
work of Demori et al., (2006) [56] and Moyà et al., 2008
[50] who showed that the liver catalase, glutathione per-
oxidase, and Mn-superoxide dismutase were reduced in
response to the cafeteria-diet feeding in obese rats.
Furthermore our correlation study indicated that there
is negative correlation between MDA and PCO levels
and enzymes activities of GPx, GST and PON 1 in the
liver, heart and renal tissues and with CAT enzyme
activity in kidney. This correlation finding conformed
and supported the concept of inactivation of antioxidant
enzymes and proteins by high level of lipid peroxidation
in obesity.
Decrease of antioxidant enzyme may be due to rapid
consumption and exhaustion of storage of this enzyme
in fighting free radicals generated during development
of obesity.
PON-1 activity could be decreased as consequence of
an altered synthesis and/or secretion of HDL secondary
to impaired lecithin cholesterol acyl transferase (LCAT)
activity.
Under oxidative stress, PON-1 may be inactivated by
Sglutathionylation a redox regulatory mechanism char-
acterized by the formation of mixed disulfide between a
protein thiol and oxidized glutathione [57].
In the present study, the non significant change in the
CAT enzyme activity in liver and heart tissues of obese
rat may be due to increases oxygen consumption of pre-
vious tissues due to obesity and the change of CAT
enzyme activity is dependent on oxygen consumption
[12,47]. As stated above, cardiac tissue of obese rats
showed significant high content of GSH compared to
normal rats. Vincent1, et al., demonstrated similar
results. Increasing of GSH concentration in cardiac tis-
sue in obese rats in response to free radical formation in
an effort to protect cells against oxidative damage [47].
The adaptation of the primary antioxidant defense in
the hearts of high-fat-fed animals appeared to be less
complete, as indicated by the failure of other antioxidant
enzyme activities including GST, GPX and PON 1 to
increase in the hearts of animals on the high-fat diet.
Table 5 Correlation matrix between MDA, PCO levels and
the studied antioxidants in liver tissues.
GSH GST GPx CAT PON1
MDA r -0.642 -0.423 -0.796 -0.325 -0.652
P-value 0.002 0.008* 0.001* 0.475 0.025*
PCO r 0.410 -0.685 -0.586 0.319 -0.420
P-value 0.001* 0.001* 0.017* 0.112 0.039*
Table 6 Correlation matrix between MDA, PCO levels and
the studied antioxidants in heart tissues.
GSH GST GPx CAT PON1
MDA r 0.597 -0.841 -0.684 -0.201 -0.583
P-value 0.042* 0.041* 0.021* 0.523 0.030*
PCO r 0.410 0.685 0.586 0.355 -0.523
P-value 0.001* 0.001* 0.017* 0.099 0.022*
Table 7 Correlation matrix between MDA, PCO levels and
the studied antioxidants in kidney tissues.
GSH GST GPx CAT PON1
MDA r -0.538 -0.417 -0.745 -0.492 -0.639
P-value 0.022* 0.028* 0.044* 0.020* 0.011*
PCO r 0.410 0.685 0.586 0.458 -0.752
P-value 0.001* 0.001* 0.017* 0.007* 0.009*
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or PCO levels and CAT enzyme activity in the liver and
heart tissues.
Conclusion
High fat diet-induced obesity is accompanied by
increased hepatic, heart, and renal tissues oxidative
stress, which is characterized by reduction in the antiox-
idant enzymes activities and glutathione levels, that cor-
relate with the increase in MDA and PCO levels in
most tissues. This may probably contribute to the addi-
tional progression of obesity related problems.
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